Visilizumab in severe ulcerative colitis: good vision but blurry results.
Sparrow
Miles
M
Inflammatory Bowel Disease Clinical Trials, Department of Gastroenterology, Box Hill Hospital, Melbourne, Victoria, Australia.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D006801:Humans; D007239:Infections / Q000209:etiology; D013601:T-Lymphocytes / Q000187:drug effects
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C456519:visilizumab